Small, modular nuclear reactor designs could be relatively cheap to build and safe to operate, and there’s plenty of corporate and government momentum behind a push to develop and license them. But will they be able to offer power cheap enough to compete with natural gas? And will they really help revive the moribund nuclear industry in the United States?
Last year, the U.S. Department of Energy announced that it would provide $452 million in grants to companies developing small modular reactors, provided the companies matched the funds (bringing the total to $900 million). In November it announced the first grant winner—Babcock & Wilcox, a maker of reactors for nuclear ships and submarines—and this month it requested applications for a second round of funding. The program funding is expected to be enough to certify two or three designs.
The new funding is on top of the hundreds of millions of dollars Babcock & Wilcox has already spent on developing its 180-megawatt reactor design, along with a test facility to confirm its computer models of the reactor. Several other companies have also invested in small modular reactors, including Holtec, Westinghouse Electric, and the startup NuScale, which is supported by the engineering firm Fluor (see “Small Nukes Get a Boost,” “Small Nuclear Reactors Get a Customer,” and “Giant Holes in the Ground”).
The companies are investing in the technology partly in response to requests from power providers. One utility, Ameren Missouri, the biggest electricity supplier in that state, is working with Westinghouse to help in the certification process for that company’s small reactor design. Ameren is particularly worried about potential emissions regulations, because it relies on carbon-intensive coal plants for about 80 percent of its electricity production.
As Ameren anticipates shutting down coal plants, it needs reliable power to replace the baseload electricity they produce. Solar and wind power are intermittent, requiring fossil-fuel backup, notes Pat Cryderman, the manager for nuclear generation development at Ameren. “You’re really building out twice,” he says. That adds to the costs. And burning the backup fuel, natural gas, emits carbon dioxide.
Nuclear reactors that generate over 1,000 megawatts each can cost more than $10 billion to build, an investment that’s extremely risky for a company whose total assets are only $23 billion. Power plants based on small modular reactors, which produce roughly 200 to 300 megawatts, are expected to cost only a few billion dollars, a more manageable investment. “They’re simply more affordable,” says Robert Rosner, coauthor of a University of Chicago study of potential costs that the DOE has drawn on in evaluating the potential of small reactors.
The smaller size has other potential advantages. Siting a large nuclear power plant can be difficult—it requires, for example, an emergency planning zone extending 10 miles around the plant, Cryderman says. That zone could be as small as half a mile for a small modular reactor—in part because of its size and in part because the reactors have added design features. For example, while the newest reactors—such as the Westinghouse AP1000—are designed to keep the fuel cool for three days without power, small modular reactors can be designed to go without any power for weeks. He says that if the Nuclear Regulatory Commission approves a smaller emergency planning zone, that could allow Ameren to build nuclear power plants at old coal plant sites, simplifying grid connections and other siting issues.
The smaller size is also an advantage in the United States, where power demand is growing slowly and many utilities don’t want to add multiple gigawatts at a time. The modular reactors are expected to take much less time to build as well, so utilities need to forecast demand only a few years out rather than more than a decade, Cryderman says.
Yet questions remain about the viability of small nuclear reactors. While their up-front cost is lower than that of larger reactors, they might prove to cost more per kilowatt of capacity—and per kilowatt-hour of power generated.
Nuclear power plants are built large to achieve economies of scale. “Designers could make the reactors put out more power, but they didn’t have to increase the capital costs proportionally,” says John Kelly, deputy assistant secretary for nuclear reactor technologies at the Department of Energy. The hope, he says, is that building the reactors in factories will provide an alternative way to reduce costs—through mass production. The small reactors are also simpler in some ways, which can also reduce costs.
But whether those savings will be realized is uncertain. It’s not clear how many reactors need to be built before the potential savings from factory production kick in, and whether there will be enough orders for reactors to hit those numbers. For that to happen, Rosner suggests, the government may have to be the first customer, buying the reactors for military bases or government labs.
Even once the final design is approved by the NRC, costs could prove higher than expected once the plants are actually built. “Part of the problem when you start in on these things, especially with a new technology, is that all the news after you begin is bad,” says Michael Golay, a professor of nuclear science and engineering at MIT. “Things never behave in an optimized fashion.”
Even if small reactors can compete with conventional nuclear power, they still might not be able to compete with natural-gas power plants, especially in the United States, where natural gas is cheap (see “Safer Nuclear Power, at Half the Price”). Their success will depend on how much utilities think they need to hedge against a possible rise in natural-gas prices over the lifetime of a plant—and how much they believe they’ll be required to reduce carbon dioxide emissions.
“At the end of the day, we’ll build the lowest-cost option for ratepayers,” Cryderman says. “If it’s too expensive, we won’t build it.” The challenge, he says, is predicting what the lowest-cost options will be over the decades new plants will operate.
Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.
These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.